(Q38700564)

PubMed publication ID

28605599

5 September 2017

title

STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

1 reference

L L Bu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

G T Yu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

L Wu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

L Mao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

W W Deng

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

J F Liu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

A B Kulkarni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

W F Zhang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

L Zhang

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

Z J Sun

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

language of work or name

English

0 references

publication date

1 June 2017

1 reference

PubMed publication ID

28605599

Journal of Dental Research

5 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

page(s)

1027-1034

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now.

12 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

The role of STATs in transcriptional control and their impact on cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Targeting STAT3 signaling reduces immunosuppressive myeloid cells in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Melanoma in 2015: Immune-checkpoint blockade - durable cancer control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Immunology and Immunotherapy of Head and Neck Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Type I interferon-enhanced IL-10 expression in human CD4 T cells is regulated by STAT3, STAT2, and BATF transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

The activation of MAPK in melanoma cells resistant to BRAF inhibition promotes PD-L1 expression that is reversible by MEK and PI3K inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Squamous Cell Tumors Recruit γδ T Cells Producing either IL17 or IFNγ Depending on the Tumor Stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Combination cancer immunotherapy and new immunomodulatory targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Therapeutic modulators of STAT signalling for human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Leptin-Induced JAK/STAT Signaling and Cancer Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

NFATc1 regulates PD-1 expression upon T cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

PD-1 and PD-1 ligands: from discovery to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Immunotherapy: Anti-PD-1 therapies-a new first-line option in advanced melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

IFN-α directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Characterization of key transcription factors as molecular signatures of HPV-positive and HPV-negative oral cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0022034517712435

PI3K and STAT3: a new alliance.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28605599

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

PD-L1 expression in tonsillar cancer is associated with human papillomavirus positivity and improved survival: implications for anti-PD1 clinical trials.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28605599

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1177/0022034517712435

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6728673&resulttype=core&format=json

12 May 2020

PubMed publication ID

28605599

1 reference